Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Minoxidil can cause deadly skin reaction; monitor patients closely.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Finasteride doesn't affect ovulation in normal women.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Genetics and hormones cause hair loss; finasteride treats it safely.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.